These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4397633)

  • 1. Assessment of -adrenergic blocking and non-specific properties of propranolol.
    Coltart DJ
    Br Heart J; 1971 Jul; 33(4):615. PubMed ID: 4397633
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of propranolol, practolol, trasicor and visken on cardiac chronotropism and supraventricular or ventricular arrhythmias].
    Goch JH
    Pol Tyg Lek; 1972 Dec; 27(52):2049-51. PubMed ID: 4405621
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-adrenergic blockade and antiarrhythmic activity of (-)- and (+)-propranolol.
    Flórez J; Pomar JL; Malpartida F
    Rev Esp Fisiol; 1969 Dec; 25(4):287-92. PubMed ID: 4401670
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proxodolol--a new beta- and alpha-adrenoblockader].
    Iuzhakov SD; Dolgun OV; Dorodnikova EV; Aniukhovskiĭ EP; Baldenkov GN; Rozenshtraukh LV; Medvedev OS; Mashkovskiĭ MD
    Eksp Klin Farmakol; 1994; 57(3):30-3. PubMed ID: 7914115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of heart repolarization through beta receptor blockade and its determination with spatial T-area vector in a decreasing heart rate].
    Schönberger W; Schönberger G; Bretz H
    Z Kardiol; 1973 Jun; 62(6):509-15. PubMed ID: 4147588
    [No Abstract]   [Full Text] [Related]  

  • 7. Actions of beta-adrenergic blocking drugs assessed in patients with aortic Starr-Ewards prostheses.
    Crouchman M; Gibson D; Hamer J
    Br Heart J; 1972 Sep; 34(9):963. PubMed ID: 4403881
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of beta-adrenergic receptor blockade in the treatment of cardiac arrhythmias.
    Pitt B
    Md State Med J; 1970 Jul; 19(7):30-1. PubMed ID: 4399737
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pindolol. New beta blocking agent. Effect on cardiac chronotropism and ionotropism and comparison of its activity with propranolol].
    Aquaro G; Baduini G; Pavia M; Poletti T
    Minerva Cardioangiol; 1972 Jun; 20(6):324-9. PubMed ID: 4402731
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects on the hemodynamics and myocardial contractility of 2 beta blockader agents: propranolol and proctolol].
    Sanguinetti M; Picchio FM; Maresta A; Branzi A; Baccarani G; Binetti G
    G Ital Cardiol; 1972; 2(5):710-9. PubMed ID: 4404053
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies with long acting propranolol.
    Shanks RG
    Postgrad Med J; 1984; 60 Suppl 2():61-8. PubMed ID: 6463010
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs.
    Jaillon P; Hecklé J; Weissenburger J; Cheymol G
    J Pharmacol Exp Ther; 1980 Feb; 212(2):347-53. PubMed ID: 6101348
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of adrenergic beta receptor blocking with propranolol on the electrocardiographic changes caused by pitressin].
    Romeo F; Squadrito G; Nicita-Mauro V
    Atti Soc Ital Cardiol; 1968; 2():77-81. PubMed ID: 5743877
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrophysiological characteristics of tobanum, a new beta receptor blocking agent.
    Solti F; Czakó E
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):229-32. PubMed ID: 6104635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of obsidan for increasing exercise tolerance in elderly patients with ischemic heart disease].
    Kotko DN; Fed'ko GP; Iaroshenko IuT
    Ter Arkh; 1980; 52(8):22-5. PubMed ID: 6114575
    [No Abstract]   [Full Text] [Related]  

  • 16. Antagonism of cardiac arrhythmias by beta-adrenoreceptor blocking agents.
    Laddu AR; Kumakura S; Somani P
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):168-81. PubMed ID: 4404932
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of blocking the beta-adrenergic receptors on ventricular diastole and on the systole of the left atrium in normal subjects. (Evaluation with the polygraphic method)].
    Vitale P; Mazza F; Jacono A
    Minerva Cardioangiol; 1971 Aug; 19(8):418-23. PubMed ID: 4397763
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate.
    Billman GE
    J Pharmacol Exp Ther; 1994 Apr; 269(1):409-16. PubMed ID: 7909562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical pharmacology of beta-sympathicolysis. Comparative trial of LB 46 and propranolol].
    Lang E; Haas W; Heck J
    Med Klin; 1970 Dec; 65(50):2206-11. PubMed ID: 4399179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.